OncoCyte (OCX) Appoints Peter Gutfreund to its Board

Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today announced the appointment of John Peter (JP) Gutfreund as an independent member of its board of directors, effective July 28, 2022.

“We welcome JP to our Board of Directors at what we believe to be an important time in the life of Oncocyte, as we anticipate bringing three major products through reimbursement and to market over the next four quarters,” said Ron Andrews, CEO of Oncocyte. “He brings a wealth of financial experience to our team, and his expertise will be immensely valuable as we look to balance our need to manage our cash while effectively executing on the growth phase ahead."

Since October 2019, Mr. Gutfreund has served as Managing Partner of Halle Capital Management, a growth oriented private equity firm focused on middle-market companies in the healthcare, consumer, and business services sectors. Mr. Gutfreund serves on the board of several Halle portfolio companies. Mr. Gutfreund is a trustee at Montefiore Health System, a New York based academic health system, where he serves as a member of the investment committee. Prior to joining Halle Capital Management, Mr. Gutfreund was the Director of Research at Glenview Capital Management from March 2013 to September 2019. Mr. Gutfreund worked in Investment Banking earlier in his career and holds a BA from New York University.

“I am thrilled to be joining the Oncocyte Board of Directors," said Mr. Gutfreund. "Oncocyte is on an exciting path, with multiple products in the pipeline, and I look forward to working with the Board to support management's vision for shareholder value creation.”

You May Also Be Interested In

• Z Squared outlines AI power strategy and Paradox Data acquisition
• Sprinklr adds Microsoft's Jordi Ribas to its board of directors
• Bausch + Lomb names Appio as chairman, reshapes board committees